Stock Market Today, March: CytomX Surges on Positive Data
CytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
Mistakes disrupt budgets and derail goals. Explore how small oversights impact finances and how to recalibrate for stable, predictable spending.
27,871 articlesCytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
A China-based AI software company is powering a sharp move in the market. This article breaks down why yuanbao stock ...
A bank ETF can be a reliable engine for a value-focused portfolio, capturing the cash-generating power of U.S. lender...
I’ve spent week world’s top AI talks and the takeaway is sharp: talent battles and new pricing models will ripple thr...
When markets hit new highs, Berkshire Hathaway's leaders offer a different playbook. Learn how Warren Buffett's Greg ...
Investors buzzed as CoreWeave shares jumped, sparking questions about the catalysts behind the surge. This guide brea...
Investors are weighing a bold claim: prediction: will lose value for XRP. This article breaks down what could drive X...
In 2026, savvy investors favor dividend stocks that reliably pay and grow. This article highlights two no-brainer div...
Curious about a strategy that blends stock ownership with option income? This deep-dive on the JPMorgan Equity Premiu...
Regulators green-light a new type of BTC trading on Kalshi. Learn how the CFTC's approval of Bitcoin perpetual future...
A rising dividend-focused approach suggests a portfolio that pays more can replace a minimum-wage check, but it deman...
C3.ai saw a sharp drop after its latest results, renewing debate about whether the stock is a value play or a value t...